Guillain-Barré Syndrome (GBS) is a rare but serious neurological condition that can develop suddenly, often after a common infection. While the name may not be familiar to many, understanding the ...
Brazil: Brazilian researchers have found in a new study, published in The New England Journal of Medicine, that dengue ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Annexon Biosciences has announced positive topline ...
Guillain Barr The Food and Drug Administration (FDA) has granted Fast Track designation to ANX005 (Annexon Biosciences) for the treatment of Guillain-Barré Syndrome (GBS), an autoimmune disease that ...
The American College of Physicians (ACP) issued updated vaccine practice points for physicians that advise adults aged 75 or older should receive a protein subunit Respiratory Syncytial Virus (RSV) ...
SAN DIEGO -- A single dose of investigational tanruprubart resulted in rapid, sustained improvement in disability compared with placebo in patients with Guillain-Barré syndrome (GBS), a phase III, ...
KYOTO, Japan — Eculizumab (Soliris, Alexion Pharmaceuticals) is safe for the treatment of patients with severe Guillain-Barré syndrome (GBS), a new phase 2 study shows. However, although more patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results